Home » Topics » Regulatory

Regulatory
RSS

Glaxo Wellcome claims new formulation of anxiolytic agent

Jan. 23, 1997

Asta seeks rights to impotency Rx

Jan. 21, 1997

Olopatadine studied for allergic conjunctivitis

Jan. 20, 1997

Mochida claims new formulation for ulinastatin

Jan. 20, 1997

Takeda claims new approach to diabetes Rx

Jan. 20, 1997

FDA approves topical acne treatment

Jan. 17, 1997

New treatment option for HIV-infected children

Jan. 17, 1997

New impotence Rx now available in U.S.

Jan. 16, 1997

Approval sought for Androtest-SL

Jan. 16, 1997

Generic version of Monistat-7 approved by FDA

Jan. 16, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 15, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 16, 2025.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
FDA greenlights Medtronic Onyx subdural hematoma treatment
BioWorld MedTech
Sometimes the darkest products (names) bring a bright spot of news to their developers, as the U.S. FDA clearance for Galway, Ireland-based Medtronic plc's Onyx...